OPEN END TURBO LONG - RESMED | Real-time Bid/Ask 04:35:05 2024-06-18 am EDT | ||
| 0.78 EUR / 0.98 EUR | +2.33% |
|
| Current month | +43.33% | ||
| 1 month | -51.41% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RESMED, INC.
Latest news about RESMED, INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-18 | 0.81 | -5.81% |
| 24-06-17 | 0.86 | -11.34% |
| 24-06-14 | 0.97 | -10.19% |
| 24-06-13 | 1.08 | +11.34% |
| 24-06-12 | 0.97 | +16.87% |
Delayed Quote Börse Stuttgart
Last update June 18, 2024 at 02:52 am EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | RESMED, INC. |
| Issuer | Morgan Stanley |
| WKN | MG3B9S |
| ISIN | DE000MG3B9S5 |
| Date issued | 2024-04-30 |
| Strike | 202.4 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.83 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.98 € |
|---|---|
| Lowest since issue | 0.44 € |
| Spread | 0.2 € |
| Spread % | 20.62% |
Company Profile
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Sector
-
Consensus: ResMed, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
210.4
USD
Average target price
218.7
USD
Spread / Average Target
+3.98%
- Stock Market
- Certificates
- Certificat
